<doc>
  <docmeta id="113s1128is">
    <bill congress="113" type="s" number="1128" version="is"/>
    <revision size="3504" annotations="0" status="complete" id="7" commit-time="2013-07-05T19:02:57Z" committer="mbohmer" doc="113s1128is/7.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<metadata>
<dublinCore>
<title>113 S1128 IS: Preserving Access to Orphan Drugs Act of 2013</title>
<publisher>U.S. Senate</publisher>
<date/>
<format>text/xml</format>
<language>EN</language>
<rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 1128</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date>June 11, 2013</action-date>
			<action-desc>
        <sponsor name-id="S351">Mr. Toomey</sponsor> (for himself,
			 <cosponsor name-id="S309">Mr. Casey</cosponsor>, and <cosponsor name-id="S266">Mr. Crapo</cosponsor>) introduced the following bill; which was
			 read twice and referred to the <committee-name committee-id="SSFI00">Committee
			 on Finance</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To clarify the orphan drug exception to the annual fee on
		  branded prescription pharmaceutical manufacturers and
		  importers.</official-title>
	</form>
	<legis-body id="H217770B9975B48CAAAB6B8922A9E76CD" style="OLC">
		<section id="id64E34FE6BA7241F7BD9DAFA155AD7940" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>
            Preserving Access to Orphan Drugs Act
			 of 2013
          </short-title>
        </quote>.</text>
		</section>
    <section id="H0919A08248C6450AA5F781AFC9E3A146" section-type="subsequent-section">
      <enum>2.</enum>
      <header>Clarification of
			 orphan drug exception to annual fee on branded prescription pharmaceutical
			 manufacturers and importers</header>
			<subsection commented="no" id="HC6CAA135FAAF4644886FCF712C033886">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            
              <cato:entity-ref entity-type="act" value="Patient Protection and Affordable Care Act/s:9008/ss:e/p:3">Paragraph (3) of
			 section 9008(e)
             of the 
              Patient Protection and Affordable Care Act</cato:entity-ref> (<cato:entity-ref value="usc/26/4001/note" entity-type="uscode">
              <cato:entity-ref value="usc/26/4001" entity-type="uscode">26 U.S.C.
			 4001</cato:entity-ref> note prec</cato:entity-ref>.; <external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>)
          </cato:entity> is amended to read as follows:</text>
				<quoted-block display-inline="no-display-inline" id="HF27DB0DDD42C4EFB8F39B677E227B40C" style="OLC">
					<paragraph commented="no" id="H1E5CD89FCF6A4D7FA67EB61CC3A18FB8">
            <enum>(3)</enum>
            <header>Exclusion of
				orphan drug sales</header>
						<subparagraph commented="no" id="HD2670A4772D04BAFBA2A957F93416608">
              <enum>(A)</enum>
              <header>In
				general</header>
              <text display-inline="yes-display-inline">The term
				<term>branded prescription drug sales</term> shall not include sales of any
				drug or biological product—</text>
							<clause commented="no" id="H0E8214AB0ECC42EE87168BCE9F9AFD54">
                <enum>(i)</enum>
                <text>with respect to
				which a credit was allowed for any taxable year under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Internal Revenue Code of 1986/s:45C" entity-type="act">
                    <cato:entity-ref value="Internal Revenue Code of 1986/s:45C" entity-type="act">section 45C</cato:entity-ref> of the
				<cato:entity-ref value="Internal Revenue Code of 1986" entity-type="act">Internal Revenue Code of 1986</cato:entity-ref>
                  </cato:entity-ref>; or</text>
							</clause>
              <clause commented="no" id="HF708024C1FF14B80B7DCC17B8D17AE9B">
                <enum>(ii)</enum>
                <text>which is approved
				or licensed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> for marketing solely for one or
				more rare diseases or conditions.</text>
							</clause>
            </subparagraph>
            <subparagraph commented="no" id="HC21879BEC09B4C4DBE91E58F56E00989">
              <enum>(B)</enum>
              <header>Limitation</header>
              <text>
                <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Patient Protection and Affordable Care Act/s:90008/ss:e/p:3/sp:A">Subparagraph
				(A)</cato:entity-ref> shall not apply with respect to any drug or biological product after the
				date on which the drug or biological product is approved or licensed by the
				<cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> for marketing for any indication other than the
				treatment of a rare disease or condition.</text>
						</subparagraph>
            <subparagraph commented="no" id="HE2230F38AA6748E3984C9EFCD2E6E70C">
              <enum>(C)</enum>
              <header>Rare disease or
				condition</header>
              <text>In this paragraph, the term <term>rare disease or
				condition</term> has the meaning given such term under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Internal Revenue Code of 1986/s:45C/ss:d/p:1" entity-type="act">
                  <cato:entity-ref value="Internal Revenue Code of 1986/s:45C/ss:d/p:1" entity-type="act">section 45C(d)(1)</cato:entity-ref> of the
				<cato:entity-ref value="Internal Revenue Code of 1986" entity-type="act">Internal Revenue Code of 1986</cato:entity-ref>
                </cato:entity-ref>, except that in the case of any drug or
				biological product that has not been designated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug and Cosmetic Act/s:526" entity-type="act">
                  <cato:entity-ref value="Federal Food, Drug, and Cosmetic Act/s:526" entity-type="act">section 526</cato:entity-ref> of the
				<cato:entity-ref value="Federal Food, Drug, and Cosmetic Act" entity-type="act">Federal Food, Drug and Cosmetic Act</cato:entity-ref>
                </cato:entity-ref> for a particular indication, determinations
				under such <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Internal Revenue Code of 1986/s:45C/ss:d/p:1" entity-type="act">section 45C(d)(1)</cato:entity-ref> shall be made on the basis of the facts and
				circumstances as of the date such drug or biological product is approved or
				licensed by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> for marketing for the treatment of
				such disease or
				condition.</text>
						</subparagraph>
          </paragraph>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
			</subsection>
      <subsection id="H26DA77CC8C8441FBB55E0978A9162317">
        <enum>(b)</enum>
        <header>Effective
			 date</header>
        <text>The amendment made by this section shall take effect as if
			 included in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Patient Protection and Affordable Care Act/s:9008">section 9008 of the 
            Patient Protection and Affordable Care Act</cato:entity-ref> (<cato:entity-ref value="usc/26/4001/note" entity-type="uscode">26
			 U.S.C. 4001 note prec</cato:entity-ref>.; <external-xref legal-doc="public-law" parsable-cite="pl/111/148">Public Law 111–148</external-xref>
          
          </cato:entity>).</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>